ZYIL1 capsule

DRUG3 trials

Sponsors

Zydus Lifesciences Limited

Conditions

Cryopyrin Associated Periodic SyndromeHealthy

Phase 1

Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers

CompletedNCT04731324

Zydus Lifesciences LimitedHealthy

Start: 2020-12-28End: 2021-06-12Updated: 2021-06-18

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers

CompletedNCT04972188

Zydus Lifesciences LimitedHealthy

Start: 2021-07-12End: 2021-10-25Updated: 2021-11-16

Phase 2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)

CompletedNCT05186051

Zydus Lifesciences LimitedCryopyrin Associated Periodic Syndrome

Start: 2022-06-01End: 2022-07-02Updated: 2022-07-11